JPH0643436B2 - New substance trehalostatin and its production method - Google Patents
New substance trehalostatin and its production methodInfo
- Publication number
- JPH0643436B2 JPH0643436B2 JP2-503981A JP50398190A JPH0643436B2 JP H0643436 B2 JPH0643436 B2 JP H0643436B2 JP 50398190 A JP50398190 A JP 50398190A JP H0643436 B2 JPH0643436 B2 JP H0643436B2
- Authority
- JP
- Japan
- Prior art keywords
- ppm
- trehalostatin
- amycolatopsis
- trehalostatica
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
-
- C12R1/04—
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Description
【発明の詳細な説明】
[技術分野]
本発明は、新規な物質であるトレハロスタチンに係る。
また、本発明は、該新規物質トレハロスタチンの製造方
法および該新規物質を産生する放線菌にも係る。Description: TECHNICAL FIELD The present invention relates to a novel substance, trehalostatin.
The present invention also relates to a method for producing the novel substance trehalostatin and an actinomycete that produces the novel substance.
[背景技術]
トレハラーゼはα−グルコシダーゼの一種であり、カ
ビ、酵母及び多くの昆虫の血リンパ中に広く分布するト
レハロースのグルコシド結合の加水分解を特異的に触媒
する酵素である。BACKGROUND ART Trehalase is a type of α-glucosidase, an enzyme that specifically catalyzes the hydrolysis of the glucosidic bond of trehalose, which is widely distributed in the hemolymph of molds, yeasts, and many insects.
[発明の開示]
本発明者らは土壌より分離したアミコラトプシス(Amyc
olatopsis)属に属する放線菌が、その培養液および菌
体内に、昆虫、特にケブカクロバエのトレハラーゼに対
して極めて低濃度で阻害効果を示す新規な物質を産生す
ることを発見し、この物質をトレハロスタチンと命名し
た。[Disclosure of the Invention] The present inventors have isolated Amycolatopsis (Amyc
We discovered that actinomycetes belonging to the genus O. latopsis produce a novel substance in their culture medium and cells that inhibits trehalase from insects, particularly blow flies, at extremely low concentrations, and named this substance trehalostatin.
本発明は、上記の知見にもとづいて完成されたものであ
って、Amycolatopsis属に属するトレハロスタチン産生
菌を培養し、その培養物から採取した新規物質トレハロ
スタチンに関する。また、本発明は、そのような新規物
質を産生する放線菌株および該菌株を使用するトレハロ
スタチンの製造方法も提供する。The present invention was completed based on the above findings and relates to a novel substance, trehalostatin, obtained by culturing a trehalostatin-producing bacterium belonging to the genus Amycolatopsis and collecting the resulting culture. The present invention also provides an actinomycete strain that produces the novel substance and a method for producing trehalostatin using the strain.
本発明で使用できる菌としては、アミコラト プシス・
トレハロスタティカ(Amycolatopsis trehalostatica)
を始めとして、Amycolatopsis属に属する菌でトレハロ
スタチンを産生する菌はすべて本発明に使用することが
できる。Fungi that can be used in the present invention include Amycolatopsis
Trehalostatica (Amycolatopsis trehalostatica)
All trehalostatin-producing fungi belonging to the genus Amycolatopsis, including the fungi of the genus Amycolatopsis, can be used in the present invention.
特に、本発明者らが土壌より新たに分離した菌株SAM 09
67が好適に使用できる。In particular, the strain SAM 09, which we newly isolated from soil,
67 can be suitably used.
Amycolatopsis trehalostatica SAM 0967は次の菌学的
性質を有する。Amycolatopsis trehalostatica SAM 0967 has the following mycological properties:
1.形態的所見
SAM 0967株は、直径0.4-0.8μmの基底菌糸、及び
気中菌糸を形成する。基底菌糸は分岐し、まれに分断が
認められた。気中菌糸は、分岐し、その先端に10個前
後、あるいはそれ以上の胞子連鎖を形成する。胞子の大
きさは幅0.4-0.5μm、長さ0.9-1.3μmで、その表面は
平滑である。胞子嚢、菌糸束、菌核等の構造体は、21日
培養後も認められなかった。1. Morphological findings: SAM 0967 strain forms substrate and aerial hyphae with a diameter of 0.4-0.8 μm. The substrate hyphae are branched and occasionally segmented. The aerial hyphae are branched and form chains of around 10 or more spores at their tips. The spores are 0.4-0.5 μm wide and 0.9-1.3 μm long, with smooth surfaces. No structures such as sporangia, hyphal strands, or sclerotia were observed even after 21 days of culture.
2.培養所見(28℃、21日間培養)
ショ糖・硝酸塩寒天培地;気中菌糸:豊富、白;裏面の
色調:橙褐色;可溶性色素:灰紫色。2. Culture findings (cultured at 28°C for 21 days) Sucrose nitrate agar medium: Aerial mycelium: abundant, white; reverse color: orange-brown; soluble pigment: grayish purple.
グルコース・アスパラギン寒天培地;気中菌糸:豊富、
白;裏面の色調:灰橙色;可溶性色素:無し。Glucose-asparagine agar medium; aerial mycelium: abundant,
White; reverse color: grayish orange; soluble pigments: none.
グリセリン・アスパラギン寒天培地;気中菌糸:豊富、
白;裏面の色調:灰褐色;可溶性色素:橙灰色。Glycerin-asparagine agar medium; aerial mycelium: abundant,
White; reverse color: grayish brown; soluble pigment: orange-gray.
スターチ・無機塩寒天培地;気中菌糸:豊富、白;裏面
の色調:白黄色;可溶性色素:無し。Starch and inorganic salts agar medium; aerial mycelium: abundant, white; reverse color: whitish yellow; soluble pigment: none.
チロシン寒天培地;気中菌糸:豊富、裏面の色調:暗褐
色;可溶性色素:灰褐色。Tyrosine agar medium; aerial hyphae: abundant, reverse color: dark brown; soluble pigment: grayish brown.
栄養寒天培地;気中菌糸:豊富、白;裏面の色調:白黄
色;可溶性色素:無し。Nutrient agar medium; aerial mycelium: abundant, white; reverse color: whitish yellow; soluble pigment: none.
酵母エキス・麦芽エキス寒天培地;気中菌糸:豊富、
白;裏面の色調:暗褐色;可溶性色素:灰褐色。Yeast extract/malt extract agar medium; aerial mycelium: abundant,
White; reverse color: dark brown; soluble pigment: grayish brown.
オートミール寒天培地;気中菌糸:豊富、白;裏面の色
調:白黄色;可溶性色素:無し。Oatmeal agar medium; aerial mycelium: abundant, white; reverse color: whitish yellow; soluble pigment: none.
素寒天培地;気中菌糸:豊富、白;裏面の色調:白色;
可溶性色素:無し。Plain agar medium; Aerial mycelium: abundant, white; Back color: white;
Soluble pigments: None.
1/10馬鈴薯・人参寒天培地;気中菌糸:豊富、白;裏面
の色調:白黄色;可溶性色素:無し。1/10 potato-carrot agar medium; aerial mycelium: abundant, white; reverse color: whitish yellow; soluble pigment: none.
1/10V-8ジュース寒天培地;気中菌糸:豊富、白;裏面
の色調:白黄色;可溶性色素:無し。1/10V-8 juice agar medium; aerial mycelium: abundant, white; reverse color: whitish yellow; soluble pigment: none.
3.生理学的所見
生育温度範囲
酵母エキス・グルコース液体培地を用いて、16℃、19
℃、22℃、25.5℃、28.5℃、31℃、33℃、36.5℃、39.5
℃、42.5℃、45.5℃、及び47℃の各温度で試験の結果、
19℃以上、39.5℃以下で生育が認められた。生育適温
は、28.5℃から36.5℃付近と思われた。3. Physiological findings Growth temperature range: 16°C, 19°C, and 20°C in a yeast extract/glucose liquid medium.
°C, 22°C, 25.5°C, 28.5°C, 31°C, 33°C, 36.5°C, 39.5
Test results at temperatures of 42.5°C, 45.5°C, and 47°C
Growth was observed above 19°C and below 39.5°C. The optimum temperature for growth appears to be around 28.5°C to 36.5°C.
ゼラチンの液化(28℃)
グルコース・ペプトン・ゼラチン培地 陽性
単純ゼラチン培地 陽性
肉汁ゼラチン培地 陽性
スターチの加水分解 陰性
脱脂乳の凝固(28℃) 陰性
脱脂乳のペプトン化 陽性
メラニン様色素の生成
ペプトン・酵母エキス・鉄寒天培地 陰性
チロシン寒天培地 陰性
トリプトン・酵母エキス寒天培地 陰性
硝酸塩の還元 陽性
炭素源の利用性(プリドハム・ゴトリーブ寒天培地、
28℃、14日間培養)
D−グルコース +
D−キシロース +
L−ラクトース +
L−ラムノース +
L−アラビノース +
D−フルクトース +
ラティノース ±
D−マンニトール +
イノシトール +
シュクロース +
ラクトース +
但し、+;利用する、±利用するかどうか疑わしい、
−;利用しない
酸生産能
ラフィノース +
イノシトール +
D−マンニトール +
ラクトース +
ソルビトール −
エリスリトール +
L−アラビノース +
アドニトール −
D−ガラクトース +
[Gordon,R.E.et al.(International Journal of Syst
ematic Bacteriology,24巻,54ページ,1974年)の方法
による。]
4.化学的性質
2,6−ジアミノピメリン酸
全菌体、及び細胞壁の加水分解物を、Staneck,J.L.及び
Roberts,G.D.の方法(Applied Microbiology,28巻、226
ページ、1974年)に準拠して調べた結果、メソ−2,6−
ジアミノピメリン酸の存在が認められた。Gelatin liquefaction (28°C) Glucose-peptone-gelatin medium Positive Simple gelatin medium Positive Broth gelatin medium Positive Starch hydrolysis Negative Coagulation of skim milk (28°C) Negative Peptonization of skim milk Positive Formation of melanin-like pigments Peptone-yeast extract-iron agar Negative Tyrosine agar Negative Tryptone-yeast extract agar Negative Nitrate reduction Positive Carbon source utilization (Pridham-Gottlieb agar,
(Cultivated at 28°C for 14 days) D-glucose + D-xylose + L-lactose + L-rhamnose + L-arabinose + D-fructose + latinose ± D-mannitol + inositol + sucrose + lactose + However, +: utilized, ± doubtful whether utilized,
-: Unutilized acid production capacity Raffinose + Inositol + D-mannitol + Lactose + Sorbitol - Erythritol + L-arabinose + Adonitol - D-galactose + [Gordon, R.E. et al. (International Journal of Syst
24, 54, 1974.] 4. Chemical properties 2,6-diaminopimelic acid was purified by the method of Staneck, JL and others. Whole cells and cell wall hydrolysates were purified by the method of Staneck, JL and others.
Roberts, GD's method (Applied Microbiology, Vol. 28, 226
As a result of the investigation in accordance with the method described in (Page, 1974), the meso-2,6-
The presence of diaminopimelic acid was observed.
糖
全菌体の加水分解物中に、アラビノースの存在が認めら
れた。また、細胞壁の加水分解物中には、ガラクトー
ス、アラビノールの存在が認められた。Arabinose was detected in the hydrolysate of the whole cell, and galactose and arabinol were detected in the hydrolysate of the cell wall.
キノン系 MK−9(H4)を主成分に有する。Quinone-based The main component is MK-9 (H4).
リン脂質タイプ
フォスファチジルエタノールアミンを含み、フォスファ
チジルコリン、未知グルコサミン含有リン脂質を含まな
い。これは、Lechevalier,M.P.,及びH.A.Lechevalier
(The Chemotaxonomy of Actinomycetes,227-291ペー
ジ、In A.Dietz and D.W.Thayer(編)、Actinomycete
Taxonomy,Special Publication no.6.Society for Indu
strial Microbiology,U.S.A.1980年)によるP−IIタイ
プに属する。Contains phospholipid type phosphatidylethanolamine, but does not contain phosphatidylcholine or unknown glucosamine-containing phospholipids. This is based on the findings of Lechevalier, MP, and HA Lechevalier.
(The Chemotaxonomy of Actinomycetes, pages 227-291, In A.Dietz and DWThayer (eds.), Actinomycetes
Taxonomy,Special Publication no.6.Society for Indu
It belongs to the P-II type according to the American Society of Clinical Microbiology, USA, 1980.
ミコール酸 菌体内にミコール酸は含まない。Mycolic Acids The bacteria do not contain mycolic acids.
SAM 0967株の細胞壁は、メソ−2,6−ジアミノピメ
リン酸とガラクトース、アラビノースを含む IV−A
タイプである。SAM 0967株は気中菌糸を形成し、そ
の先端に平滑な胞子を連鎖状に着生する。また、キノン
系はMK−9(H4)を主成分として有し、リン脂質タ
イプはP−IIで、ミコール酸を含まない。以上の分類学
的性質よりSAM 0967株は明らかに、Amycolatopsis
属に属する放線菌である。Amycolatopsis属には現在6
種1亜種の既知種が含まれている。Lechevalier,M.P. e
t al.(International Journal of Systematic Bacteri
logy,36巻、29ページ、1986年)、及びHenssen,A.et a
l.(International Journal of Systematic Bacteriolo
gy,37巻、292ページ、1987年)に従ってSAM 0967株
の分類学的位置を検索した結果、Amycolatopsis.orient
alisとAmycolatopsis mediterraneiの2種がSAM 09
67株に近縁であった。そこでこの2種の基準菌株とSA
M 0967株について、培養性状、生理的性状、及びキノ
ン系の歯比較試験を行なった。その結果を次表に示す。The cell wall of strain SAM 0967 contains meso-2,6-diaminopimelic acid, galactose, and arabinose.
The SAM 0967 strain forms aerial hyphae, and smooth spores adhere in chains to the tips of the hyphae. The quinone system contains MK-9 (H4) as the main component, and the phospholipid type is P-II, and does not contain mycolic acid. From the above taxonomic characteristics, the SAM 0967 strain is clearly an Amycolatopsis
It is an actinomycete belonging to the genus Amycolatopsis.
Contains one known species of subspecies. Lechevalier,MP e
t al. (International Journal of Systematic Bacteri
logy, vol. 36, p. 29, 1986), and Henssen, A. et al.
l. (International Journal of Systematic Bacteriolo
The taxonomic position of strain SAM 0967 was searched according to the method of the Japanese Society of Microbiology, Vol. 37, p. 292, 1987, and it was found to be Amycolatopsis orientalis.
alis and Amycolatopsis mediterranei are SAM 09
67 strain. Therefore, the two type strains and SA
The M0967 strain was subjected to comparative tests on its cultural properties, physiological properties, and quinone activity. The results are shown in the following table.
表に示すように、SAM 0967株とAmycolatopsis orie
ntalis JCM-4600は、酵母エキス・麦芽エキス寒天培
地、無機塩・スターチ寒天培地上での気中菌糸の色調、
5% NaCl存在下での生育、シュクロースの利用性、ラフ
ィノース、エリスリトール、アドニトールからの酸生成
能、メナキノンの組成の点で明らかに区別される。As shown in the table, SAM 0967 strain and Amycolatopsis orie
ntalis JCM-4600 can measure the color of aerial mycelia on yeast extract/malt extract agar medium and inorganic salt/starch agar medium.
They are clearly distinguishable from each other in terms of growth in the presence of 5% NaCl, sucrose utilization, acid production from raffinose, erythritol, and adonitol, and menaquinone composition.
また、SAM 0967株とAmycolatopsis mediterranei J
CM-4789は気中菌糸形成能、メナキノンの組成の点で明
らかに区別される。In addition, SAM 0967 strain and Amycolatopsis mediterranei J
CM-4789 is clearly distinguishable from the others in terms of its aerial mycelium formation ability and menaquinone composition.
本発明者らは、これらの違いはSAM 0967株とこれら
の2種を区別するのに、十分な差であると判断した。そ
こでSAM 0967株を、Amycolatposis属の新種とし、A
mycolatopsis trehalostaticaと命名した。The present inventors determined that these differences were sufficient to distinguish the SAM 0967 strain from these two species. Therefore, the SAM 0967 strain was designated as a new species in the genus Amycolatposis and classified as A.
It was named mycolatopsis trehalostatica.
Amycolatopsis trehalostatica SAM 0967は、1989年2
月17日付で工業技術院生物工業技術研究所に、受託番号
微工研寄第10544号(FERM P-10544)として国内寄託さ
れ、その後、特許手続上の微生物の寄託の国際的承認に
関するブタペスト条約下の国際寄託に1990年2月28日付
で移行し、受託番号微工研条寄第2784号(FERM BP-278
4)が付されている。Amycolatopsis trehalostatica SAM 0967 was discovered in February 1989.
It was deposited domestically at the National Institute of Biotechnology, Agency of Industrial Science and Technology on February 17, 1990, under the accession number FERM P-10544, and then transferred to an international deposit under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure on February 28, 1990, under the accession number FERM BP-2784.
4) is attached.
本発明では、上記のような放線菌を培養する。その際に
使用できる培地は、液体状でも固体状でもよいが、通常
は液体培地による振盪培養または通気撹拌培養が便利で
ある。 In the present invention, the actinomycetes described above are cultured in a medium that may be either liquid or solid, but shaking culture or aeration and agitation culture in a liquid medium is usually convenient.
培地としては、本発明に係る放線菌が生育して本発明の
新規な物質を蓄積できるものであればどのようなもので
もよい。すなわち、炭素源としては、グルコース、ラク
トース、デンプン、シュクロース、デキストリン、糖
蜜、有機酸類などが、また窒素源としては、ペプトン、
カザミノ酸などの蛋白質加水分解物の他、肉エキス、酵
母エキス、ダイズ粕、コーンスティープリカー、アミノ
酸類、アンモニウム塩、硝酸塩、その他の有機あるいは
無機窒素化合物が用いられる。また、無機塩として各種
燐酸塩、硫酸マグネシウム、塩化ナトリウムなどを添加
してもよく、また菌の生育を促進する目的でビタミン
類、核酸関連化合物などを添加してもよい。なお、シリ
コン、ポリプロピレングリコール誘導体、大豆油などの
消泡材を培地に添加することが本発明の新規物質の蓄積
量を増大させるのに効果的な場合もある。The medium may be any medium that allows the actinomycete of the present invention to grow and accumulate the novel substance of the present invention. That is, the carbon source may be glucose, lactose, starch, sucrose, dextrin, molasses, organic acids, etc., and the nitrogen source may be peptone,
In addition to protein hydrolysates such as casamino acids, meat extract, yeast extract, soybean meal, corn steep liquor, amino acids, ammonium salts, nitrates, and other organic or inorganic nitrogen compounds can be used. Various inorganic salts such as phosphates, magnesium sulfate, and sodium chloride can also be added, and vitamins and nucleic acid-related compounds can also be added to promote bacterial growth. Adding antifoaming agents such as silicone, polypropylene glycol derivatives, and soybean oil to the culture medium can also be effective in increasing the accumulation of the novel substance of the present invention.
培養にあたって、いきなり本培養をするよりは、あらか
じめ小規模な前培養を行ない、その培養物を培地に接種
するのが望ましい。本培養、前培養共に、培養温度、培
養期間、培養の液性などの条件は、本発明の新規物質の
蓄積量が最大となるように適当に選択・調節されるが、
多くの場合、好気的条件下、25℃〜30℃にて培養するの
がよく、また培地の液性はpH5.5〜8.0に保つのがよい。
このように培養することにより、培養物中に本発明の新
規物質が生成・蓄積される。液体培地を用いて培養した
場合は、主としてその液体状部分に目的物が蓄積される
ので、培養物をいったん過あるいは遠心分離して菌体
を除去し、得られた液あるいは上漬からこれを分離す
るのが望ましいが、必要に応じて菌体を除去することな
く、培養液から直接目的物を分離することもできる。In culturing, it is preferable to first carry out a small-scale pre-culture and then inoculate the culture into the medium rather than immediately starting the main culture. For both the main culture and the pre-culture, the conditions such as the culture temperature, culture period, and liquid properties of the culture are appropriately selected and adjusted so as to maximize the accumulation of the novel substance of the present invention.
In most cases, cultivation is carried out under aerobic conditions at 25°C to 30°C, and the pH of the medium should be maintained at 5.5 to 8.0.
By culturing in this manner, the novel substance of the present invention is produced and accumulated in the culture. When culturing in a liquid medium, the target substance accumulates mainly in the liquid portion, so it is desirable to first filter or centrifuge the culture to remove the bacterial cells and then separate the target substance from the resulting liquid or pickle. However, if necessary, the target substance can be separated directly from the culture liquid without removing the bacterial cells.
以上のようにして本発明の新規物質トレハロスタチンを
採取する際の目的物の検出・定量は、ケブカクロバエあ
るいはブタ腎臓より調製したトレハラーゼの活性を該目
的物が阻害する程度を定量することによって行なうこと
ができる。培養物からの目的物の分離・精製には、本発
明の新規物質の化学的特性に基づく種々の手段を採用で
きる。すなわち、有機溶媒処理、セファデックスやバイ
オゲルなどによるゲル過、各種イオン交換樹脂による
イオン交換クロマトグラフィー、活性炭、シリカゲル
ル、アンバーライト-XAD-1、同-2などの吸着剤を用いる
吸着クロマトグラフィー、YMC-PA43やTSK-Amide 80など
の担体を用いる順相クロマトグラフィーなどが有効であ
り、これらの手段を適当に組合わせて使用することによ
り、本発明の新規物質トレハロスタチンが白色の無定形
結晶状に単離される。ただし、これら以外の方法であっ
ても、本発明の新規物質の特性を有効に利用するもので
あれば適宜使用できる。特に好ましい吸着剤の組合せと
しては、ダウエックス50WX4(H)、YMC-PA43、TSK-Amide
80の組合せが挙げられる。When collecting the novel substance trehalostatin of the present invention as described above, the detection and quantification of the target substance can be performed by quantifying the degree to which the target substance inhibits the activity of trehalase prepared from Aleurites or pig kidney. Various methods based on the chemical properties of the novel substance of the present invention can be used to separate and purify the target substance from the culture. Effective methods include organic solvent treatment, gel filtration using Sephadex or Biogel, ion exchange chromatography using various ion exchange resins, adsorption chromatography using adsorbents such as activated carbon, silica gel, Amberlite-XAD-1 and -2, and normal phase chromatography using carriers such as YMC-PA43 and TSK-Amide 80. By appropriately combining these methods, the novel substance trehalostatin of the present invention can be isolated in the form of white amorphous crystals. However, other methods can also be used as long as they effectively utilize the properties of the novel substance of the present invention. A particularly preferred combination of adsorbents is Dowex 50WX4(H), YMC-PA43, and TSK-Amide.
There are 80 possible combinations.
なお、本発明の新規物質は単離・精製して用いることも
できるが、場合によってはトレハロスタチン産生菌の培
養物をそのままあるいは簡単に精製しただけで用いるこ
ともできる。The novel substance of the present invention can be used after isolation and purification, but in some cases the culture of the trehalostatin-producing bacteria can be used as is or simply after purification.
図面の簡単な説明
第1図:トレハロスタチンの重水中でのH,H−COS
Yスペクトル
第2図:アセチル化トレハロスタチンのCDCl3中でのH
MBCスペクトル
第3図:トラハロスタチンの重水中での位相検知NOE
SYスペクトル
第4図:アセチル化トレハロスタチンのCDCl3中でのN
OESYスペクトル
第5図:アセチル化トレハロスタチンの2つの位置異性
体の構造と、それらのCDCl3中での1H−および13C
−NMRスペクトルデータ(非グルコース部分、斜体数
字は、13C−NMRの化学シフトを表わす)
[発明の実施するための最良の形態]
以下実施例により本発明を詳細に説明するが、本発明は
これらに限定されるものではない。BRIEF DESCRIPTION OF THE DRAWINGS Figure 1: H,H-COS of trehalostatin in heavy water
Y spectrum Figure 2: H of acetylated trehalostatin in CDCl3
MBC spectrum Figure 3: Phase-detected NOE of trahalostatin in heavy water
SY spectrum Figure 4: N of acetylated trehalostatin in CDCl3
OESY spectrum. Figure 5: Structures of two positional isomers of acetylated trehalostatin and their 1H- and 13C- spectra in CDCl3 .
- NMR spectrum data (non-glucose portion, italicized numbers represent 13 C-NMR chemical shifts) [Best Mode for Carrying Out the Invention] The present invention will be described in detail below with reference to examples, but the present invention is not limited to these.
実施例1:トレハロスタチンの製造
(1)活性測定法
トレハロスタチンの精製の各段階における阻害活性は、
以下のようにして測定した。Example 1: Production of trehalostatin (1) Activity measurement method The inhibitory activity at each stage of trehalostatin purification was measured as follows:
The measurement was carried out as follows.
インヒビター溶液10μlとトレハラーゼ溶液(ケブカク
ロバエ)10μlとを混合し、37℃で5分間インキュベー
トした後、5mMトレハロース、50mMリン酸緩衝液(pH6.
5)80μlを添加し、37℃で1時間インキュベートし
た。その後、10μlの50%トリクロロ酢酸溶液を添加し
て反応を停止させた。反応液中に生成したグルコース
を、ベーリンガー・マンハイム・山ノ内社の新ブラッド
・シュガー・テストにより定量した。酵素量は、前記方
法に従ってインヒビターを加えずに測定した場合にグル
コース定量における使用波長(660nm)の吸光度が1.0に
なる量を使用した。上記測定法で酵素(トレハラーゼ)
活性を50%阻害するトレハロスタチンの濃度を1単位/
mlとした。10 μl of the inhibitor solution was mixed with 10 μl of trehalase solution (Aedes aeruginosa), and the mixture was incubated at 37°C for 5 minutes, after which it was diluted with 5 mM trehalose, 50 mM phosphate buffer (pH 6.
5) 80 μl of the mixture was added and incubated at 37°C for 1 hour. The reaction was then stopped by adding 10 μl of 50% trichloroacetic acid solution. The glucose produced in the reaction solution was quantified using the new Blood Sugar Test from Boehringer Mannheim Yamanouchi. The amount of enzyme used was such that the absorbance at the wavelength used for glucose quantification (660 nm) was 1.0 when measured according to the above method without adding an inhibitor. The enzyme (trehalase) was measured using the above method.
The concentration of trehalostatin that inhibits activity by 50% is 1 unit/
ml.
(2)アミコラトプシス・トレハロスタチカ SAM 0967の
培養によるトレハロスタチンの製造
ジャガイモ熱水抽出物、グルコース、乾燥酵母エキス、
リン酸1カリウム、硫酸マグネシウムからなる培地3.1
L(pH7.0)に、30mlのSAM 0967株の純粋培養物を接種
し、小型培養機で28℃、通気量3/分、400rpm/分で
120時間通気撹拌培養した。(2) Production of trehalostatin by culturing Amycolatopsis trehalostatica SAM 0967. Potato hot water extract, glucose, dry yeast extract,
Medium 3.1 consisting of monopotassium phosphate and magnesium sulfate
30 ml of pure culture of SAM 0967 strain was inoculated into 1 L (pH 7.0) and incubated in a small incubator at 28°C, 3 aeration/min, and 400 rpm.
The mixture was cultured with aeration and agitation for 120 hours.
培養物を遠心分離して得られた上漬3.07L(101000単位
のトレハロスタチンを含有する)に、蟻酸を終濃度0.02
Mとなるように添加し、塩酸で溶液のpHを3.1に調整
後、これをダウエックス50W×4(H)(室町化学製)の
カラム(6×37cm)に吸着させた。このカラムを3.0L
の0.2Mピリジン−蟻酸バッファー(pH3.2)にて洗浄し
た後、ケブカクロバエのトレハラーゼを阻害する活性
を、3.5Lの0.4Mピリジン−酢酸バッファー(pH4.2)
にて溶出させた。The culture was centrifuged to obtain 3.07 L of the supernatant (containing 101,000 units of trehalostatin).
The pH of the solution was adjusted to 3.1 with hydrochloric acid, and the solution was then adsorbed onto a column (6 x 37 cm) of Dowex 50W x 4 (H) (Muromachi Chemical Co., Ltd.).
After washing with 3.5 L of 0.2 M pyridine-formic acid buffer (pH 3.2), the activity of inhibiting trehalase from Alder fly was assayed by adding 3.5 L of 0.4 M pyridine-acetate buffer (pH 4.2).
The solution was eluted with .
活性画分(120000単位のトレハロスタチンを含有する)
を減圧下で濃縮乾固し、残渣を少量の水に溶解して、溶
液のpHを塩酸で3.1にした。溶液中の不溶物を遠心分離
にて除去し、得られた上漬をダウエックス50W×4(H)
カラム(3×12cm)に負荷した。このカラムを、0.5L
の脱イオン水で洗浄し、次いで30%(v/v)メタノール
を含む3Lの0.2Mピリジン−蟻酸バッファー(pH3.2)
にて洗浄しながら目的物を溶出した。Active fraction (containing 120,000 units of trehalostatin)
The concentrate was concentrated to dryness under reduced pressure, the residue was dissolved in a small amount of water, and the pH of the solution was adjusted to 3.1 with hydrochloric acid. The insoluble matter in the solution was removed by centrifugation, and the resulting supernatant was poured into a Dowex 50W x 4 (H)
The column (3 x 12 cm) was loaded with 0.5 L of ethanol.
of deionized water, and then 3 L of 0.2 M pyridine-formate buffer (pH 3.2) containing 30% (v/v) methanol.
The target substance was eluted while washing with .
目的物の画分(120000単位のトレハロスタチンを含有す
る)を減圧下で濃縮後、残渣を50%(v/v)アセトニト
リルに均一に懸濁してこれを高速液体クロマトグラフ用
充填カラム(YMC−PA43、2.5×27cm)に負荷し
た。このカラムを65%(v/v)の定組成のアセトニトリ
ルで洗浄(流速5ml/分)し、示差屈折計にて溶出物を
検出しながら、溶離液を5.0mlずつ分画した。その結
果、トレハラーゼ阻害活性画分(119000単位のトレハロ
スタチンを含有する)は負荷後200ml付近に溶出させ
た。The target fraction (containing 120,000 units of trehalostatin) was concentrated under reduced pressure, and the residue was homogeneously suspended in 50% (v/v) acetonitrile and loaded onto a high-performance liquid chromatographic column (YMC-PA43, 2.5 x 27 cm). The column was washed with 65% (v/v) isocratic acetonitrile (flow rate: 5 ml/min). The eluate was fractionated in 5.0 ml aliquots while the eluate was monitored with a differential refractometer. The trehalase inhibitory active fraction (containing 119,000 units of trehalostatin) eluted at approximately 200 ml after loading.
目的物の画分を濃縮し、40%(v/v)アセトニトリルに
溶解してこれを高速液体クロマトグラフ用充填カラム
(TSK-Amide 80、0.7×27cm)に負荷した。このカラム
を同組成の溶媒で洗浄(流速1ml/分)し、示差屈折計
にて溶出物を検出しながら、溶離液を0.5mlずつ分画し
た。トレハラーゼ阻害活性画分は負荷後25〜30ml付近に
溶出された。目的物の画分(118000単位のトレハロスタ
チンを含有する)を濃縮乾固し、水を加えて凍結乾燥す
ることにより、純粋な目的物1mgを得た。The target fraction was concentrated and dissolved in 40% (v/v) acetonitrile, and loaded onto a high-performance liquid chromatographic column (TSK-Amide 80, 0.7 x 27 cm). The column was washed with a solvent of the same composition (flow rate 1 ml/min), and the eluate was fractionated in 0.5 ml increments while monitoring the eluate with a differential refractometer. The trehalase inhibitory activity fraction eluted at approximately 25-30 ml after loading. The target fraction (containing 118,000 units of trehalostatin) was concentrated to dryness, added with water, and lyophilized to yield 1 mg of the pure target product.
実施例2:トラハロスタチンの物理化学的性質
アミコラトプシス・トレハロスタティカ(SAM 0967)の
培養物から、実施例1に従って分離・精製された物質を
トレハロスタチンと命名した。Example 2: Physicochemical properties of trehalostatin The substance isolated and purified from the culture of Amycolatopsis trehalostatica (SAM 0967) according to Example 1 was named trehalostatin.
このトレハロスタチンの物理的・化学的性質を以下に示
す。The physical and chemical properties of this trehalostatin are shown below.
性状:白色粉末。Properties: White powder.
溶解性:水に可溶、ヘキサン、ベンゼン、エーテル、石
油エーテルに難溶。Solubility: Soluble in water, slightly soluble in hexane, benzene, ether, and petroleum ether.
紫外可視吸収スペクトル:220nm以上に吸収極大をもた
ない。UV-visible absorption spectrum: No absorption maximum above 220 nm.
呈色反応:Rydon-Smith反応に陽性。Color reaction: Positive Rydon-Smith reaction.
ニンヒドリン反応、3,6−ジニトロフタル酸反応、Elson
-Morgan反応に陰性。Ninhydrin reaction, 3,6-dinitrophthalic acid reaction, Elson
-Morgan reaction was negative.
薄層クロマトグラフィー:Rf=0.37
Merck Kieselgel 60 F254、展開溶媒(n−ブタノー
ル:酢酸:水=3:1:2)。Thin layer chromatography: Rf=0.37 Merck Kieselgel 60 F 254 , developing solvent (n-butanol:acetic acid:water=3:1:2).
高速液体クロマトグラフィー:Rt=11.0分 YMC PA03(0.7×27cm) 溶媒;65%v/vアセトニトリル(in H2O) 流速;1.0ml/分 検出;示差屈折計。High performance liquid chromatography: Rt = 11.0 min. YMC PA03 (0.7 x 27 cm) Solvent: 65% v/v acetonitrile (in H2O ) Flow rate: 1.0 ml/min Detection: differential refractometer.
分子量:366(m/z 367、M+H、SIMSによる)
[α]D;+115°1
H−NMR/D2O:3.3(ppm),dd,1H
3.5(ppm),m,1H
3.5(ppm),t,1H
3.6(ppm),d,1H
3.6(ppm),dd,1H
3.7(ppm),d,1H
3.7(ppm),dd,1H
3.8(ppm),ddd,1H
4.1(ppm),dd,1H
4.2(ppm),d,1H
4.8(ppm),ddd,1H
5.2(ppm),d,1H13
C−NMR/D2O:63.5(ppm)
64.8(ppm)
72.4(ppm)
72.8(ppm)
74.8(ppm)
75.8(ppm)
76.2(ppm)
83.0(ppm)
83.2(ppm)
83.4(ppm)
85.6(ppm)
89.9(ppm)
163.8(ppm)
以下の結果より推定される構造式は以下の式1、式2の
とおりである。Molecular weight: 366 (m/z 367, M+H, by SIMS) [α] D ; +115° 1H -NMR/ D2O : 3.3 (ppm), dd, 1H 3.5 (ppm), m, 1H 3.5 (ppm), t, 1H 3.6 (ppm), d, 1H 3.6 (ppm), dd, 1H 3.7 (ppm), d, 1H 3.7 (ppm), dd, 1H 3.8 (ppm), ddd, 1H 4.1 (ppm), dd, 1H 4.2 (ppm), d, 1H 4.8 (ppm), ddd, 1H 5.2 (ppm), d, 1H 13 C-NMR/D 2 O: 63.5 (ppm) 64.8 (ppm) 72.4 (ppm) 72.8 (ppm) 74.8 (ppm) 75.8 (ppm) 76.2 (ppm) 83.0 (ppm) 83.2 (ppm) 83.4 (ppm) 85.6 (ppm) 89.9 (ppm) 163.8 (ppm) The structural formulas estimated from the results below are as shown in Formula 1 and Formula 2 below.
さらにトレハロスタチンの構造を以下のように決定し
た。なお、化学シフトは、トレハロスタチンの場合は25
℃の重水中での測定値であり、アセチル化トレハロスタ
チンの場合は25℃のCDCl3中での測定値である。またと
くにことわらないかぎり、本文中の化学シフトは前者を
あらわすものとする。また、文中のDISとはDeuteriu
m induced Differential isotope shiftの略称であり、
DIS=δ13CH2O−δ13CD2O(ppm)
で定義される。もしある炭素原子に−OH基や−NH基
のような重水素交換可能な官能基が結合していると、そ
の炭素原子のDISは0.02−0.1ppm程度の正の値をあた
える。 Furthermore, the structure of trehalostatin was determined as follows. The chemical shifts for trehalostatin were 25
In the case of acetylated trehalostatin, the measurements were taken in deuterated water at 25°C, and in the case of deuterated water, the measurements were taken in CDCl3 at 25°C. Unless otherwise specified, the chemical shifts in the text refer to the former.
DIS is an abbreviation for m-induced Differential isotope shift, and is defined as DIS = δ 13 CH 2 O - δ 13 CD 2 O (ppm). If a carbon atom has a deuterium-exchangeable functional group such as an -OH group or an -NH group bonded to it, the DIS of that carbon atom will have a positive value of about 0.02-0.1 ppm.
まず、トレハロスタチンがα−D−グルコピラノシル基
を含有することを、以下のようなMS,NMR,および
化学的解析により明らかにした。すなわち液体SIMS
(Liquid Secondary lon Mass Spectrometry)法で生成
するm/z367[M+H]+の分子イオンピークが、B/E-li
nked Scan(B/E一定リンク走査)にてm/z205[M+
H−C6H10O5]+のフラグメントを生成したこと
から、ヘキソース残基の存在を推定した。1H−NMR
(表B),およびH,H−COSYスペクトル(H/H
同種核シフト相関NMR分光法(第1図)においてグル
コピラノシル基のスピン系を見いだし、さらにアノメリ
ック水素(5.2ppm)のカップリング定数(J=5.0Hz)
に基づいて、これをα−グルコピラノシル基と同定し
た。また、トレハロスタチンを塩酸−メタノール処理す
ると、シリカゲル薄層クロマトグラフィーでメチルグル
コシドと同一の移動度をもつ単糖類を生成した。この単
糖類をアセチル後、シリカゲルカラムクロマトグラフィ
ーにて単離し、その1H−NMRスペクトルを標準標品
と比較することにより、メチルグルコピラノシド(アセ
チル化物)と同定し、グルコプラノシル基の存在をさら
に確認した(表A)。このアセチル化メチルグルコピラ
ノシドをp−ブロモ安息香酸のテトラエステルに変換し
て円二色性スペクトル測定を行なったことろ、244nmにp
ositive split CDシグナルを与えたので、このグルコピ
ラノシル基の絶対配置をD型と決定した。さらα−D−
グルコピラノシル基のアノメリック炭素(83.4ppm)
が、O−グルコシドにみられるより高磁場シフトしてい
ることから、このα−D−グルコピラノシル基がN−グ
ルコシドであることが示唆された。First, it was revealed that trehalostatin contains an α-D-glucopyranosyl group by the following MS, NMR, and chemical analyses: Liquid SIMS
The molecular ion peak of m/z 367 [M+H] + generated by Liquid Secondary Ion Mass Spectrometry (LIMS) was determined to be B/E-li.
Linked Scan (B/E constant link scan)
The presence of a hexose residue was inferred from the formation of a fragment of [H-C6H10O5 ] + .
(Table B), and H, H-COSY spectrum (H/H
Homonuclear shift correlation NMR spectroscopy (Figure 1) revealed the spin system of the glucopyranosyl group, and furthermore, the coupling constant (J = 5.0 Hz) of the anomeric hydrogen (5.2 ppm) was determined.
Based on this, this was identified as an α-glucopyranosyl group. Furthermore, when trehalostatin was treated with hydrochloric acid-methanol, a monosaccharide was produced that exhibited the same mobility as methyl glucoside in silica gel thin-layer chromatography. This monosaccharide was acetylated and isolated by silica gel column chromatography. By comparing its 1H -NMR spectrum with that of a standard, it was identified as methyl glucopyranoside (acetylated product), further confirming the presence of the glucoplanosyl group (Table A). This acetylated methyl glucopyranoside was converted to a tetraester of p-bromobenzoic acid and subjected to circular dichroism spectroscopy, revealing a peak at 244 nm.
Since the α-D-glucopyranosyl group gave a positive split CD signal, the absolute configuration of this glucopyranosyl group was determined to be D-type.
Anomeric carbon of glucopyranosyl group (83.4 ppm)
However, the upfield shift observed for the O-glucoside suggested that this α-D-glucopyranosyl group was an N-glucoside.
次にトレハロスタチンの非グルコース部分の構造を以下
のように決定した。Next, the structure of the non-glucose portion of trehalostatin was determined as follows.
分子量(366)から計算されるトレハロスタチンの不飽
和度は4であり、本物質はα−D−グルコピラノシル基
(不飽和度1)を含有するから、非グルコース部分の不
飽和度は3である。さらにIR(1616cm-1),UV(末
端吸収),13C−NMR(163.8ppm)によりウレイド
基(不飽和度1)の存在が示唆されるから、非グルコー
ス部分は2環式であると考えた。1H−NMR,13C
−NMR,DEPT(Distortionless Enhancement by
polarization Transfer)により得られた、トレハロス
タチンの各水素と炭素のスペクトルデータを、H,C−
COSYスペクトル(H/C異種核シフト相関NMR分
光法)により相関させた(表B)。またアセチル化トリ
ハロスタチンの2つの異性体の非グルコース部分の各水
素と炭素を、HMQC(1H-Detected Multiple Quantum
Coherence Spectrum)により相関させた(第5図)。The degree of unsaturation of trehalostatin calculated from its molecular weight (366) is 4, and since this substance contains an α-D-glucopyranosyl group (degree of unsaturation 1), the degree of unsaturation of the non-glucose portion is 3. Furthermore, IR (1616 cm -1 ), UV (terminal absorption), and 13C -NMR (163.8 ppm) suggest the presence of a ureido group (degree of unsaturation 1), so the non-glucose portion is considered to be bicyclic. 1H -NMR, 13C
-NMR, DEPT (Distortionless Enhancement by
The spectral data of each hydrogen and carbon of trehalostatin obtained by polarization transfer was analyzed using H, C-
The correlation was carried out by COSY spectroscopy (H/C heteronuclear shift correlation NMR spectroscopy) (Table B). In addition, each hydrogen and carbon of the non-glucose portion of the two isomers of acetylated trihalostatin was analyzed by HMQC ( 1H -Detected Multiple Quantum
The correlation was performed using the Coherence Spectrum (Coherence Spectrum) (Figure 5).
H,H−COSYスペクトルから、この非グルコース部
分には、4.2、4.8、4.1、3.8ppmの4つの水素(それぞ
れH3′,H4′,H5′,H6′)をもつスピン系が
存在することがわかった(第1図)。それらの水素が結
合する炭素(それぞれC3′,C4′,C5′,C
6′)の化学シフトの大きさ(表B)は、これらの水素
が5員環の骨格に含まれることを示唆している。そして
アセチル化トレハロスタチンのHMBC(1H−Detect
ed Multiple-bond Heternuclear Multiple Quantum Coh
erence Spectrum)において、上述のスピン系の両末端
の水素(H3′,アセチル化物では例えば5.92ppm;お
よびH6′,アセチル化物では例えば6.35ppm)が、s
p3−4級炭素(C2′,アセチル化物では例えば86.5
ppm)に対してクロスピークを与えること(第2図)か
ら、上述のスピン系は、このsp3−4級炭素とともに
5員環炭素骨格を構成することが明らかとなった。ま
た、独立したメチレン水素(H1′a,アセチル化物で
例えば3.94ppm;及びH1′b,アセチル化物で例えが
4.21ppm)もsp3−4級炭素(C2′,アセチル化物
では例えば86.5ppm)に対してクロスピークを与えた
(第2図)。以上の結果から、次のような部分構造が考
えられた。The H,H-COSY spectrum revealed that the non-glucose portion contains a spin system with four hydrogen atoms (H3', H4', H5', and H6') at 4.2, 4.8, 4.1, and 3.8 ppm (Figure 1). The carbon atoms to which these hydrogen atoms are bonded (C3', C4', C5', and C6', respectively)
The magnitude of the chemical shifts of the acetylated trehalostatin (HMBC) and the acetylated trehalostatin ( HMBC ) of ...
ed Multiple-bond Heternuclear Multiple Quantum Coh
In the frequency spectrum, the hydrogen atoms at both ends of the spin system (H3', e.g., 5.92 ppm in the acetylated product; and H6', e.g., 6.35 ppm in the acetylated product) are
p 3 -quaternary carbon (C2', for example, 86.5 in the acetylated product)
From the cross peaks (Figure 2) for the sp 3 -quaternary carbon, it is clear that the above spin system forms a five-membered carbon skeleton together with this sp 3 -quaternary carbon. In addition, independent methylene hydrogens (H1'a, e.g., 3.94 ppm in the acetylated product; and H1'b, e.g., 1.00 ppm in the acetylated product) are also observed.
4.21 ppm) also gave a cross peak to the sp 3 -quaternary carbon (C2', for example, 86.5 ppm in the acetylated product) (Figure 2). From the above results, the following partial structure was suggested.
上述のスピン系を構成する炭素のうち末端の炭素の一つ
(C3′,76.2ppm)は、アセチル化によって、より高
磁場で共鳴する(アセチル化で例えば58.3ppmになる、
第5図)ことから、この炭素には窒素原子が結合してい
ることが示唆され、さらにこの炭素にDIS(>+0.0
7)が観察されることから、この炭素にはNH基が結合
することが示された。またアセチル化により、3.6,3.7
ppmのメチレン水素(H1′a,H1′b)および4.1、
3.8ppmの各水素(H5′,H6′)が大きく低磁場シフ
トすること(アセチル化で、例えばそれぞれ3.9、4.2、
5.4、6.4ppmになる(第5図))から、これらの水素が
結合する炭素(C1′,63.5;C5′,83.2;C6′,
83.0ppm)には水酸基が結合していることがわかり、そ
れはDISの結果(それぞれ+0.06,+0.04,+0.07pp
m)からも支持された。一方、89.9ppmの炭素(C4′)
にはDISが認められず(CIS<0)、アセチル化に
よってもH4′が低磁場シフトしないこと(表Bおよび
第5図)から、このC4′に結合する酸素は水酸基以外
のものであることがわかった。以上の結果から、非グル
コース部分は、ウレイド(イソウレイド)基を含有する
疑似環状糖アルコールであると考えた(式3参照)。 One of the terminal carbons (C3', 76.2 ppm) that make up the spin system described above resonates at a higher magnetic field due to acetylation (for example, 58.3 ppm).
5), it is suggested that a nitrogen atom is bonded to this carbon, and furthermore, this carbon has a DIS (>+0.0
7) was observed, indicating that an NH group is bonded to this carbon.
ppm methylene hydrogens (H1′a, H1′b) and 4.1,
The hydrogens (H5', H6') at 3.8 ppm shift significantly downfield (e.g., 3.9, 4.2,
5.4, 6.4 ppm (Figure 5)), and the carbons to which these hydrogens are bonded (C1', 63.5; C5', 83.2; C6',
83.0 ppm) were found to have hydroxyl groups bonded, which was confirmed by the DIS results (+0.06, +0.04, +0.07 ppm, respectively).
m), while 89.9 ppm of carbon (C4')
Since no DIS was observed (CIS<0) and acetylation did not result in a downfield shift of H4' (Table B and Figure 5), it was determined that the oxygen attached to this C4' was something other than a hydroxyl group. Based on these results, we hypothesized that the non-glucose moiety was a pseudocyclic sugar alcohol containing a ureido (isoureido) group (see Formula 3).
非グルコース部分の相対的な立体配置を、NOESY実
験により以下のように決定した。4.2ppm(H3′)と4.
8ppm(H4′)の水素間(J=8.6Hz)、および4.1ppm
(H5′)と3.8ppm(H6′)の水素間(J=4.8Hz)
にそれぞれNOEが観察されたことから、それらは互い
にsynの関係にあることがわかった。4.8ppmの水素(H
4′)と4.1ppmの水素(H5′)の間(J=2.7Hz)に
はNOEが無いことから、それらはantiの関係にあるこ
とがわかった(第3図)。また、アセチル化トエハロス
タチンの非グルコース部分について、C2′(アセチル
化物で86.5ppm)に結合する水酸基と、H3′(アセチ
ル化物で5.92ppm)の間にNOEが観測されたことは、
それらがsynの関係にあることをあらわしている(第4
図,第5図)。またアセチル化トレハロスタチンのふた
つの異性体のうち、一方のN−アセチル基のメチル水素
(2.66ppm)が、グルコース残基の3位の水素(アセチ
ル化物で5.39ppm)との間にNOEをもつことから、こ
のものは、グルコースに結合する窒素原子にアセチル基
をもち、もう一方は、N3′−位にアセチル基をもつ位
置異性体であることがわかった(第4図,第5図)。The relative configurations of the non-glucose moieties were determined by NOESY experiments as follows: 4.2 ppm (H3') and 4.
Between hydrogens (J = 8.6 Hz) at 8 ppm (H4') and 4.1 ppm
Between hydrogen (H5') and 3.8 ppm (H6') (J = 4.8 Hz)
Since NOEs were observed at each of these sites, it was found that they were in a syn relationship with each other.
Since there was no NOE between the hydroxyl group (H4') at 4.1 ppm and the hydrogen (H5') at 4.1 ppm (J = 2.7 Hz), it was found that they are in an anti-relationship (Figure 3). In addition, in the non-glucose portion of acetylated toehalostatin, an NOE was observed between the hydroxyl group attached to C2' (86.5 ppm in the acetylated product) and H3' (5.92 ppm in the acetylated product).
This shows that they are in a syn relationship (4th
In addition, of the two isomers of acetylated trehalostatin, one has an NOE between the methyl hydrogen of the N-acetyl group (2.66 ppm) and the hydrogen at the 3-position of the glucose residue (5.39 ppm in the acetylated product), indicating that this isomer has an acetyl group at the nitrogen atom bound to glucose, while the other is a positional isomer with an acetyl group at the N -3 ' position (Figs. 4 and 5).
以上の結果から、トレハロスタチンについて得られたス
ペクトルデータを満足する構造を以下のように決定した
(式3)。なお、非グルコース部分の構造は、その鏡像
体も可能である。From the above results, the structure of trehalostatin that satisfies the spectral data obtained was determined as follows (Formula 3): Note that the structure of the non-glucose portion may also be its enantiomer.
なお、トレハラーゼを阻害するためには、ウレイド基、
イソウレイド基、もしくはアミジン基の窒素原子の一つ
が結合するN−α−グルコピラノシドが有効であると考
えられる。In order to inhibit trehalase, a ureido group,
N-α-glucopyranosides, in which one of the nitrogen atoms of the isoureido or amidine group is bonded, are thought to be effective.
実施例3.トレハロスタチンの酵素阻害スペクトル
[産業上の利用可能性]
本発明のトレハロスタチンは、昆虫、特にケブカクロバ
エのトレハラーゼに対して極めて低濃度でも有効な阻害
効果を示すものであり、これら昆虫に対する殺虫剤とし
て有用なものである。 Example 3. Enzyme inhibition spectrum of trehalostatin INDUSTRIAL APPLICABILITY The trehalostatin of the present invention exhibits an effective inhibitory effect on trehalase of insects, particularly blow flies, even at extremely low concentrations, and is useful as an insecticide against these insects.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 (C12P 19/28 C12R 1:01) ───────────────────────────────────────────────────────── Continued from the front page (51) Int.Cl. 5 Identification symbol Internal reference number FI Technical marking location (C12P 19/28 C12R 1:01)
Claims (7)
ーテルおよび石油エーテルに難溶である白色粉末であっ
て、紫外可視吸収スペクトルが220nm以上に吸収極大を
もたず、Rydon-Smith反応に陽性であり、ニンヒドリン
反応、3,6−ジニトロフタル酸反応およびElson-Morg
an反応に陰性であり、n−ブタノール:酢酸:水=3:
1:2の展開溶媒を用いたMerck kieselgel 60 F254薄
層クロマトグラフィーにおいてRf=0.37であり、流速
1.0ml/分の65%v/vアセトニトリル(H2O中)を溶媒
とするYMC PAO3(0.7×27cm)高速液体クロマトグラフ
ィーにおいてRt=11.0分であり、分子量366、[α]
D;+115°、及び以下に示すNMRスペクトル:1 H−NMR/D2O:3.3(ppm),dd,1H 3.5(ppm),m,1H 3.5(ppm),t,1H 3.6(ppm),d,1H 3.6(ppm),dd,1H 3.7(ppm),d,1H 3.7(ppm),dd,1H 3.8(ppm),ddd,1H 4.1(ppm),dd,1H 4.2(ppm),d,1H 4.8(ppm),ddd,1H 5.2(ppm),d,1H13 C−NMR/D2O:63.5(ppm) 64.8(ppm) 72.4(ppm) 72.8(ppm) 74.8(ppm) 75.8(ppm) 76.2(ppm) 83.0(ppm) 83.2(ppm) 83.4(ppm) 85.6(ppm) 89.9(ppm) 163.8(ppm) を有する新規物質トレハロスタチン。Claim 1: A white powder that is soluble in water and sparingly soluble in hexane, benzene, ether, and petroleum ether, has an ultraviolet-visible absorption spectrum with no absorption maximum above 220 nm, is positive in the Rydon-Smith reaction, and is also positive in the ninhydrin reaction, 3,6-dinitrophthalic acid reaction, and Elson-Morg reaction.
The an reaction was negative, and the n-butanol:acetic acid:water ratio was 3:
The Rf was 0.37 in thin layer chromatography on Merck Kieselgel 60 F 254 using a 1:2 developing solvent, and the flow rate was
The Rt was 11.0 min in high-performance liquid chromatography on a YMC PAO3 (0.7 x 27 cm) column using 65% v/v acetonitrile in H2O at 1.0 ml/min, and the molecular weight was 366, [α]
D : +115° and the following NMR spectra: 1 H-NMR/D 2 O: 3.3 (ppm), dd, 1H 3.5 (ppm), m, 1H 3.5 (ppm), t, 1H 3.6 (ppm), d, 1H 3.6 (ppm), dd, 1H 3.7 (ppm), d, 1H 3.7 (ppm), dd, 1H 3.8 (ppm), ddd, 1H 4.1 (ppm), dd, 1H 4.2 (ppm), d, 1H 4.8 (ppm), ddd, 1H 5.2 (ppm), d, 1H 13 C-NMR/D 2 O: 63.5 (ppm), 64.8 (ppm), 72.4 (ppm), 72.8 (ppm). 74.8 (ppm) 75.8 (ppm) 76.2 (ppm) 83.0 (ppm) 83.2 (ppm) 83.4 (ppm) 85.6 (ppm) 89.9 (ppm) 163.8 (ppm) A new substance, trehalostatin, has the following values:
属する放線菌を培養して得られることを特徴とする請求
の範囲1に記載のトレハロスタチン。2. The trehalostatin according to claim 1, which is obtained by culturing an actinomycete belonging to the genus Amycolatopsis.
AM 0967(FERMP-10544;BP-2784)であることを特徴とす
る請求の範囲2に記載のトレハロスタチン。[Claim 3] The actinomycete is Amycolatopsis trehalostatica S
3. The trehalostatin according to claim 2, which is AM 0967 (FERMP-10544; BP-2784).
産生するアミコラトプシス(Amycolatopsis)属に属す
る放線菌を培養することからなるトレハロスタチンの製
造方法。4. A method for producing trehalostatin, which comprises culturing the actinomycete belonging to the genus Amycolatopsis that produces the trehalostatin according to claim 1.
AM 0967(FERMP-10544;BP-2784)であることを特徴とす
る請求の範囲4に記載の方法。[Claim 5] The actinomycete is Amycolatopsis trehalostatica S
5. The method according to claim 4, characterized in that the strain is AM 0967 (FERMP-10544; BP-2784).
ycolatopsis trehalostatica SAM 0967(FERM P-10544;
BP-2784)。Claim 6: Amycolatopsis trehalostatica Am
ycolatopsis trehalostatica SAM 0967(FERM P-10544;
BP-2784).
に対して阻害効果を示す、請求の範囲1に記載のトレハ
ロスタチンを含有するAmycolatopsis trehalostatica S
AM 0967(FERM P-10544;BP-2784)の培養物。7. Amycolatopsis trehalostatica S. containing the trehalostatin according to claim 1, which exhibits an inhibitory effect on trehalase of insects, particularly blow flies.
Culture of AM 0967 (FERM P-10544; BP-2784).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2-503981A JPH0643436B2 (en) | 1989-02-28 | 1990-02-28 | New substance trehalostatin and its production method |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4539489 | 1989-02-28 | ||
| JP1-45394 | 1989-02-28 | ||
| JP2-503981A JPH0643436B2 (en) | 1989-02-28 | 1990-02-28 | New substance trehalostatin and its production method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO1990010010A1 JPWO1990010010A1 (en) | 1991-01-10 |
| JPH0643436B1 JPH0643436B1 (en) | 1994-06-08 |
| JPH0643436B2 true JPH0643436B2 (en) | 1994-06-08 |
Family
ID=12718048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2-503981A Expired - Lifetime JPH0643436B2 (en) | 1989-02-28 | 1990-02-28 | New substance trehalostatin and its production method |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5169778A (en) |
| EP (1) | EP0414914B1 (en) |
| JP (1) | JPH0643436B2 (en) |
| AT (1) | ATE105562T1 (en) |
| CA (1) | CA2028117C (en) |
| DE (1) | DE69008795T2 (en) |
| DK (1) | DK0414914T3 (en) |
| ES (1) | ES2052250T3 (en) |
| WO (1) | WO1990010010A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0414914B1 (en) * | 1989-02-28 | 1994-05-11 | Suntory Limited | New substance trehalostatin and production thereof |
| US5260447A (en) * | 1991-02-15 | 1993-11-09 | Sankyo Company, Limited | Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use |
| JPH05279374A (en) * | 1992-03-31 | 1993-10-26 | Sawao Murao | Suidatrestin and its production |
| JPH0932942A (en) * | 1995-07-18 | 1997-02-07 | F M Valve Seisakusho:Kk | Check valve device |
| IS6389A (en) * | 2001-08-31 | 2003-03-03 | Heraeus Kulzer Gmbh & Co. Kg | Experiences of antibiotic coating of carcasses containing microspheres, and also of such coated carcasses and their use |
| JP2010512733A (en) | 2006-12-13 | 2010-04-30 | ディーエスエム アイピー アセッツ ビー.ブイ. | Method for preparing pravastatin |
| CN116478880B (en) * | 2023-04-25 | 2024-12-06 | 昆明学院 | A strain of Amycoticola tucumiensis KC 316 and its application |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1544068A (en) * | 1977-03-30 | 1979-04-11 | Bayer Ag | Amino-sugar derivatives |
| GB8700513D0 (en) * | 1987-01-09 | 1987-02-11 | Pfizer Ltd | Antibiotics produced by fermentation |
| US4981799A (en) * | 1987-08-21 | 1991-01-01 | Takeda Chemical Industries, Ltd. | Acylamino acid racemase, production and use thereof |
| EP0414914B1 (en) * | 1989-02-28 | 1994-05-11 | Suntory Limited | New substance trehalostatin and production thereof |
-
1990
- 1990-02-28 EP EP90903931A patent/EP0414914B1/en not_active Expired - Lifetime
- 1990-02-28 JP JP2-503981A patent/JPH0643436B2/en not_active Expired - Lifetime
- 1990-02-28 WO PCT/JP1990/000264 patent/WO1990010010A1/en not_active Ceased
- 1990-02-28 ES ES90903931T patent/ES2052250T3/en not_active Expired - Lifetime
- 1990-02-28 AT AT9090903931T patent/ATE105562T1/en not_active IP Right Cessation
- 1990-02-28 US US07/601,738 patent/US5169778A/en not_active Expired - Fee Related
- 1990-02-28 CA CA002028117A patent/CA2028117C/en not_active Expired - Fee Related
- 1990-02-28 DK DK90903931.5T patent/DK0414914T3/en active
- 1990-02-28 DE DE69008795T patent/DE69008795T2/en not_active Expired - Fee Related
-
1992
- 1992-09-21 US US07/948,236 patent/US5372816A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0643436B1 (en) | 1994-06-08 |
| DK0414914T3 (en) | 1994-07-04 |
| US5372816A (en) | 1994-12-13 |
| DE69008795T2 (en) | 1994-08-25 |
| EP0414914B1 (en) | 1994-05-11 |
| CA2028117C (en) | 2000-08-01 |
| US5169778A (en) | 1992-12-08 |
| EP0414914A4 (en) | 1991-07-24 |
| CA2028117A1 (en) | 1990-08-29 |
| ES2052250T3 (en) | 1994-07-01 |
| EP0414914A1 (en) | 1991-03-06 |
| WO1990010010A1 (en) | 1990-09-07 |
| DE69008795D1 (en) | 1994-06-16 |
| ATE105562T1 (en) | 1994-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR930010705B1 (en) | Method of manufacturing FR-900520 material | |
| US4487925A (en) | Rebeccamycin and process for its preparation | |
| JPH0566394B2 (en) | ||
| US4252898A (en) | Antibiotics A6888C and A6888X | |
| JPH0643436B2 (en) | New substance trehalostatin and its production method | |
| EP0050724B1 (en) | Process for anthracycline glycosides | |
| EP0871638B1 (en) | Novel aminooligosaccharide derivative and process for preparing the same | |
| JPWO1990010010A1 (en) | New substance trehalostatin and its production method | |
| US4358584A (en) | Antibiotics A6888C and A6888X | |
| US4292309A (en) | Antibiotics C-14482 B1, B2 and B3 | |
| JP3048513B2 (en) | 2,2'-bipyridine derivative, method for producing the same, and antitumor agent containing the derivative | |
| US4686308A (en) | Novel physiologically active substance MH435 | |
| US4835141A (en) | Neutral macrolide antibiotics from Streptomyces | |
| US5021549A (en) | Physiologically active substances, probestin and prostatin and production thereof | |
| JP3068700B2 (en) | Novel trehazolin derivatives and their production | |
| JP2592468B2 (en) | Benanomycins A and B, novel antibiotics and their production | |
| JP3209791B2 (en) | Oxazoline derivative and method for producing the same | |
| JPH10114777A (en) | Antibiotic Spiroximycin and Its Production | |
| JP3530563B2 (en) | KO-8119 substance and process for producing the same | |
| US4956283A (en) | Process for preparing macrolide antibiotics by culturing streptomyces hirsutus ATCC 53513 | |
| US4310627A (en) | Process of producing 3-trehalosamine by fermentation | |
| KR0163660B1 (en) | Method for preparing SAPH derivatives having antimicrobial-anticancer activity using SA-246 strain of genus Micromonospora | |
| EP0205981B1 (en) | A novel anti-tumor and antimicrobial compound, its microbiological preparation and its use as medicament | |
| JPH05279374A (en) | Suidatrestin and its production | |
| EP0191399B1 (en) | Benz[a]anthraquinone compounds, a microbial process for their preparation and their use as medicaments |